the evolving treatment paradigm for relapsed/refractory multiple myeloma
Published 2 years ago • 43 plays • Length 36:34Download video MP4
Download video MP3
Similar videos
-
36:05
using novel therapeutic agents in early treatment for relapsed and refractory multiple myeloma
-
38:53
maximizing the possibilities in the evolving treatment paradigm for r/r follicular lymphoma
-
6:48
louis williams, ash 2019: genetic segmentation and targeted therapeutics for multiple myeloma
-
1:30
the evolving treatment landscape for multiple myeloma
-
2:39
future directions for multiple myeloma treatment
-
1:46
changes in the myeloma treatment paradigm
-
2:23:24
imf virtual regional community workshop (rcw) - south atlantic
-
37:21
key considerations for treatment selection and sequencing in patients with rrmm
-
2:17
cilta-cel: a paradigm shift in the treatment of multiple myeloma
-
4:33
standard treatment options for multiple myeloma
-
44:44
2019 multiple myeloma symposium | novel and next generation therapy
-
1:35
controlling multiple myeloma
-
5:46
where in the treatment sequence should car t-cells be used for myeloma?
-
2:45
value and cost of multiple myeloma therapy
-
3:14
what are the frontline myeloma treatment options?
-
3:11
new treatment strategies for multiple myeloma
-
1:43
improving the qol of patients with multiple myeloma treated with car-t therapy
-
1:07
mrd-guided treatment in multiple myeloma
-
2:56:05
advances in myeloma treatments: what patients & caregivers need to know